Adaptive Biotechnologies Insider Sold Shares Worth $897,356, According to a Recent SEC Filing

MT newswire2026/10/19 08:07

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

04:07 AM EDT, 10/19/2026 (MT Newswires) -- Julie Rubinstein, President and Chief Operating Officer, on October 14, 2026, sold 35,643 shares in Adaptive Biotechnologies (ADPT) for $897,356. Following the Form 4 filing with the SEC, Rubinstein has control over a total of 377,802 shares of the company, with 377,802 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1478320/000178066426000041/xslF345X05/form4.xml

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

In an email, NVIDIA's new Chairman of the Board Harvey Jones stated that the board takes its duty as guardian of this great company very seriously. The company's strength comes from our employees, leadership team, technological capabilities, and partner ecosystem. We will continue to drive business growth and lead the industry forward. Thank you all for your focus, professionalism, and dedication to NVIDIA.

华尔街见闻•2026/11/12 19:11

ICAN requests the US Supreme Court to review the standard for determining investment contracts

AiCoin•2026/11/12 19:01

Updated Version 1 - Corteva Shares Plunge as CEO Warns Brazil’s Economic Downturn Will Persist

路透社•2026/11/12 18:46